As an Amazon Associate we earn from qualifying purchases
Calm, cool, and collected. Daily Soothe is your go-to calming serum, designed to reduce redness, soothe irritation, and bring balance back to your skin. Packed with antioxidants and dermatologist-backed ingredients, this lightweight calming serum helps fight breakouts, minimize pores, and support a healthy skin barrier—without clogging or drying you out. Whether you're managing flare-ups or just keeping things in check, this daily-use calming serum delivers gentle, effective results for all skin types, especially sensitive and acne-prone
AQUA, NIACINAMIDE, PENTYLENE GLYCOL, SORBITAN OLEATE DECYLGLUCOSIDE CROSSPOLYMER, XANTHAN GUM, CITRIC ACID, SODIUM BENZOATE, MANNITOL, POTASSIUM SORBATE, DISODIUM EDTA, SODIUM HYALURONATE, SODIUM CHLORIDE, ERGOTHIONEINE
***
Ingredients are subject to change at the manufacturer's discretion. For the most complete and up-to-date list of ingredients, refer to the product packaging.
32.4% ingredient match
Shared: 6 ingredients
Original only:
PENTYLENE GLYCOL, SORBITAN OLEATE DECYLGLUCOSIDE CROSSPOLYMER, CITRIC ACID (+4 more)
Alternative only:
PROPANEDIOL, ZINC PCA, GLYCERIN (+1 more)
32.4% ingredient match
Shared: 6 ingredients
Original only:
PENTYLENE GLYCOL, SORBITAN OLEATE DECYLGLUCOSIDE CROSSPOLYMER, CITRIC ACID (+4 more)
Alternative only:
PROPANEDIOL, ZINC PCA, GLYCERIN (+1 more)
32.2% ingredient match
Shared: 7 ingredients
Original only:
PENTYLENE GLYCOL, SORBITAN OLEATE DECYLGLUCOSIDE CROSSPOLYMER, MANNITOL (+3 more)
Alternative only:
ALOE BARBADENSIS LEAF JUICE, GLYCERIN, ZINC PCA (+3 more)
31.9% ingredient match
Shared: 8 ingredients
Original only:
PENTYLENE GLYCOL, SORBITAN OLEATE DECYLGLUCOSIDE CROSSPOLYMER, MANNITOL (+2 more)
Alternative only:
PROPYLENE GLYCOL, BUTYLENE GLYCOL, DIPEPTIDE-4 (+5 more)
31.6% ingredient match
Shared: 6 ingredients
Original only:
SORBITAN OLEATE DECYLGLUCOSIDE CROSSPOLYMER, XANTHAN GUM, MANNITOL (+4 more)
Alternative only:
BUTYLENE GLYCOL, ACETYL GLUCOSAMINE, HYDROXYETHYLCELLULOSE (+1 more)
Comments 0